Year in Review: RTP Expansions
It’s certainly been an eventful year for the Research Triangle Park. There’s a lot we could talk about: grant funding and capital infusion, conferences and events, a new CEO for RTP. But one of the most exciting topics has been growth and expansion over the past year. In 2011, over 750,000 sq.ft. of new office and industrial space was announced by various Park companies. Several of these projects are now well into the construction phase, or even complete. Here’s a quick breakdown of what’s been going on in 2011:
In September, Fidelity Investments purchased a group of four office buildings on NC Highway 54 formerly occupied by Nortel Networks. Fidelity is renovating the 676,000 sq.ft. of space, and will then consolidate its regional operations into one campus. This one purchase will go a long way towards reducing vacant space in RTP and rejuvenating its building stock.
Medicago held the ribbon cutting for its new $42 million, 97,000 sq.ft. facility in November. Breathing new life into North Carolina’s heritage, Medicago will produce influenza vaccines developed using tobacco leaves. Their cGMP facility has the capacity to produce more than 40 million doses of seasonal influenza vaccine or 120 million doses of pandemic influenza vaccine per year.
RTI International, our flagship research institute, held its grand opening for Building O9 in April. The office facility is a 127,000 sq.ft. companion to Building O8, completed several years earlier. Both facilities have been certified LEED Gold. RTI is now looking into opportunities to develop greenhouse space and a biocrude pilot production plant, either in RTP or nearby.
Syngenta Biotechnology is reinventing a site on Davis Drive that was home to one of the Research Triangle Park’s first buildings. Read more »

